The nocebo effect challenges the non-medical infliximab switch in practice

BACKGROUND: In clinical practice, non-medical switching of biological medication may provoke nocebo effects due to unexplained deterioration of therapeutic benefits. Indication extrapolation, idiosyncratic reactions, and interchangeability remain challenged in clinical practice after biosimilar appr...

Descripción completa

Detalles Bibliográficos
Autores principales: Boone, N. W., Liu, L., Romberg-Camps, M. J., Duijsens, L., Houwen, C., van der Kuy, P. H. M., Janknegt, R., Peeters, R., Landewé, R. B. M., Winkens, B., van Bodegraven, A. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Pharmacoepidemiology and Prescription
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5893662/
https://www.ncbi.nlm.nih.gov/pubmed/29368188
http://dx.doi.org/10.1007/s00228-018-2418-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5893662/
https://www.ncbi.nlm.nih.gov/pubmed/29368188
http://dx.doi.org/10.1007/s00228-018-2418-4

Ejemplares similares